PL2480218T3 - Kapsułki odporne na kwas - Google Patents

Kapsułki odporne na kwas

Info

Publication number
PL2480218T3
PL2480218T3 PL10759732T PL10759732T PL2480218T3 PL 2480218 T3 PL2480218 T3 PL 2480218T3 PL 10759732 T PL10759732 T PL 10759732T PL 10759732 T PL10759732 T PL 10759732T PL 2480218 T3 PL2480218 T3 PL 2480218T3
Authority
PL
Poland
Prior art keywords
acid resistant
resistant capsules
capsules
acid
resistant
Prior art date
Application number
PL10759732T
Other languages
English (en)
Polish (pl)
Inventor
Dominique Nicolas Cade
Xiongwei David He
Original Assignee
Capsugel Belgium Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsugel Belgium Nv filed Critical Capsugel Belgium Nv
Publication of PL2480218T3 publication Critical patent/PL2480218T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/003Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor characterised by the choice of material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14Dipping a core
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29DPRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D22/00Producing hollow articles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2001/00Use of cellulose, modified cellulose or cellulose derivatives, e.g. viscose, as moulding material
    • B29K2001/08Cellulose derivatives
    • B29K2001/12Cellulose acetate
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2003/00Use of starch or derivatives as moulding material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2005/00Use of polysaccharides or derivatives as moulding material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2089/00Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/712Containers; Packaging elements or accessories, Packages
    • B29L2031/7174Capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL10759732T 2009-09-24 2010-09-14 Kapsułki odporne na kwas PL2480218T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24539209P 2009-09-24 2009-09-24
PCT/IB2010/054131 WO2011036601A1 (en) 2009-09-24 2010-09-14 Acid resistant capsules
EP10759732.0A EP2480218B1 (en) 2009-09-24 2010-09-14 Acid resistant capsules

Publications (1)

Publication Number Publication Date
PL2480218T3 true PL2480218T3 (pl) 2020-11-16

Family

ID=43027570

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10759732T PL2480218T3 (pl) 2009-09-24 2010-09-14 Kapsułki odporne na kwas

Country Status (16)

Country Link
US (4) US8852631B2 (https=)
EP (1) EP2480218B1 (https=)
JP (1) JP5777625B2 (https=)
KR (1) KR101762460B1 (https=)
CN (1) CN102665697B (https=)
AU (1) AU2010299527A1 (https=)
BR (1) BR112012006651B1 (https=)
CA (1) CA2775227C (https=)
CO (1) CO6531471A2 (https=)
DK (1) DK2480218T3 (https=)
ES (1) ES2804779T3 (https=)
MX (1) MX2012003540A (https=)
PL (1) PL2480218T3 (https=)
RU (1) RU2012116362A (https=)
TW (1) TW201127370A (https=)
WO (1) WO2011036601A1 (https=)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852631B2 (en) 2009-09-24 2014-10-07 Capsugel Belgium Nv Acid resistant capsules
JP6219836B2 (ja) 2011-11-09 2017-10-25 キャプシュゲル・ベルジウム・エヌ・ヴィ 耐酸性ツーピースハードカプセル用の耐酸性バンディング溶液
EP3446713A3 (en) 2012-05-02 2019-05-15 Capsugel Belgium NV Aqueous dispersions of controlled release polymers and shells and capsules thereof
ES2879892T3 (es) 2012-05-21 2021-11-23 Capsugel Belgium Nv Uso de una solución banda resistente a los ácidos para sellar cápsulas duras de dos piezas
WO2013174884A1 (en) 2012-05-23 2013-11-28 Capsugel France SAS Capsules having an incorporated taste modifying component
JP2014172850A (ja) * 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
JP6133702B2 (ja) * 2013-06-18 2017-05-24 紀州技研工業株式会社 インクジェットインキ、その製造方法及びその使用方法
US20160256399A1 (en) 2013-11-04 2016-09-08 Capsugel Belgium Nv Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
JP6060102B2 (ja) * 2014-03-13 2017-01-11 紀州技研工業株式会社 インクジェットインク及びその作製方法並びにインクジェットインクを用いた印字方法
CN103893772B (zh) 2014-04-21 2015-08-26 湖南尔康制药股份有限公司 一种羟丙基淀粉空心胶囊及其制备工艺
CN103937038B (zh) * 2014-04-28 2016-08-17 中国科学院化学研究所 用于制备空心胶囊的组合物及其淀粉基质空心胶囊
JP6297441B2 (ja) * 2014-07-31 2018-03-20 森永乳業株式会社 ビフィドバクテリウム属細菌含有カプセルおよびその製造方法
WO2016017006A1 (ja) * 2014-07-31 2016-02-04 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ カプセル製剤
EP3028694B1 (en) 2014-12-02 2017-07-12 Capsugel Belgium NV Dosage form articles for delayed release
EP3236993B1 (en) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
EP3244906B1 (en) * 2015-01-13 2020-02-19 New Chapter, Inc. Vegetarian capsules containing supercritical herbal extracts
EP3566699A1 (en) 2015-11-10 2019-11-13 Capsugel Belgium NV Acid resistant banding or sealing solution for acid resistant two piece hard capsules
US20170157058A1 (en) * 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
EP3246000A1 (en) 2016-05-18 2017-11-22 Capsugel Belgium NV Separable capsule for sprinkling applications
EP3272340A1 (en) 2016-07-22 2018-01-24 Capsugel Belgium NV Acid resistant capsules
EP4516356A3 (en) 2016-08-24 2025-05-14 Prilenia Neurotherapeutics Ltd. Use of pridopidine for treating functional decline
JP2018199631A (ja) * 2017-05-26 2018-12-20 株式会社ファンケル ビフィズス菌含有カプセル製剤
BR112020000011A2 (pt) 2017-07-11 2020-07-21 Qualicaps Co., Ltd. cápsula dura entérica
CO2017007322A1 (es) * 2017-07-24 2019-01-31 Novamed S A Cápsulas duras resistentes al ácido con bajo contenido de coadyuvantes de gelificacion
JP2020530494A (ja) 2017-08-07 2020-10-22 フィンチ セラピューティクス、インコーポレイテッド. 健康な腸バリアを維持及び回復するための組成物及び方法
US11083738B2 (en) 2017-09-28 2021-08-10 Natals, Inc. Dietary nutrient compositions
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
KR20200125637A (ko) 2018-02-23 2020-11-04 크레스토보 홀딩스 엘엘씨 마이크로바이옴 관련 면역요법
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
US11654184B2 (en) 2018-03-20 2023-05-23 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
EP3768773B1 (en) * 2018-03-21 2025-06-18 Altria Client Services LLC Vaporizer capsules and methods of manufacture
EP3549578A1 (en) * 2018-04-06 2019-10-09 Bio Minerals N.V. Silicic acid formulation and use thereof
KR20210022716A (ko) 2018-06-22 2021-03-03 쿠오리카프스 가부시키가이샤 장용성 경질 캡슐
EP3632449A1 (en) 2018-10-05 2020-04-08 Bio Minerals N.V. Silicic acids for use in the treatment of periodontitis
EP3650011A1 (en) 2018-11-09 2020-05-13 Bio Minerals NV Water soluble silicon-containing granulate
KR102182326B1 (ko) * 2019-02-19 2020-11-24 주식회사 서흥 내산성 셀룰로오스 캡슐의 제조방법
EP3937909B1 (en) * 2019-03-14 2026-03-04 Evonik Operations GmbH Capsule shell comprising a core-shell polymer and a cellulose
EP3999637B1 (en) 2019-07-18 2025-04-02 Theriva Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
PH12021553137A1 (en) 2019-07-19 2022-07-25 Finch Therapeutics Holdings Llc Methods and products for treatment of gastrointestinal disorders
AU2020346061A1 (en) 2019-09-13 2022-03-31 Finch Therapeutics Holdings Llc Compositions and methods for treating Autism Spectrum Disorder
WO2021076920A1 (en) * 2019-10-16 2021-04-22 Capsugel Belgium Nv Method and composition for increasing muscle protein synthesis
US20220370393A1 (en) * 2019-10-16 2022-11-24 Capsugel Belgium Nv Method and composition for increasing muscle protein synthesis
CN115279382A (zh) 2019-10-18 2022-11-01 芬奇治疗控股有限责任公司 用于向受试者递送细菌代谢物的组合物和方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療b型肝炎(hbv)及d型肝炎(hdv)之組合物及方法
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
US20230201265A1 (en) 2020-03-31 2023-06-29 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
CN120694962A (zh) * 2020-05-31 2025-09-26 艾尔金制药有限公司 硬胶囊剂型和其用途
WO2022055993A1 (en) * 2020-09-08 2022-03-17 The Johns Hopkins University Method of treatment of irritable bowel syndrome
JP2023553309A (ja) * 2020-11-25 2023-12-21 キャプシュゲル・ベルジウム・エヌ・ヴィ 二重層遅延放出硬質カプセル
JP7719609B2 (ja) * 2021-02-12 2025-08-06 クオリカプス株式会社 腸溶性硬質カプセル
WO2022178294A1 (en) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject
WO2022244713A1 (ja) * 2021-05-18 2022-11-24 ロンザ株式会社 非ゼラチン硬カプセル及びその製造方法
JP2024526149A (ja) * 2021-06-24 2024-07-17 ロンザ・グリーンウッド・エルエルシー 消化管への活性物質の投与を制御する方法
EP4442255A4 (en) 2021-11-30 2025-11-19 Qualicaps Co Ltd HARD CAPSULE, PREPARED SOLUTION FOR HARD CAPSULE AND PROCESS FOR PREPARING HARD CAPSULE
CN118340904B (zh) * 2024-04-19 2025-04-15 山东赫尔希胶囊有限公司 一种羟丙甲纤维素成膜组合物及其应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144225A (en) 1965-09-07 1969-03-05 Dow Chemical Co Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers
US4756902A (en) 1986-06-02 1988-07-12 Warner-Lambert Company Capsule sealing process and product
US5006346A (en) 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5264223A (en) 1990-03-29 1993-11-23 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JP3116602B2 (ja) 1992-10-06 2000-12-11 シオノギクオリカプス株式会社 硬質カプセル
US5431917A (en) 1992-10-08 1995-07-11 Japan Elanco Company, Ltd. Hard capsule for pharmaceutical drugs and method for producing the same
JPH07196478A (ja) 1993-12-30 1995-08-01 Hajime Sugii 安全性の高い食品及び医薬品用ソフトカプセル
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
FR2757173A1 (fr) 1996-12-17 1998-06-19 Warner Lambert Co Compositions polymeres d'origine non-animale pour la formation de films
JP4249816B2 (ja) 1997-02-24 2009-04-08 富士カプセル株式会社 ソフトカプセル
CA2307887A1 (en) 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
JP3449253B2 (ja) 1998-10-29 2003-09-22 シオノギクオリカプス株式会社 硬質カプセルの製造方法
JP2000212070A (ja) 1999-01-25 2000-08-02 Su Heung Capsule Co Ltd 植物性ハ―ド空カプセル及びその製造方法
JP3716901B2 (ja) 1999-04-14 2005-11-16 シオノギクオリカプス株式会社 セルロースエーテルフィルム
US6294008B1 (en) 1999-04-21 2001-09-25 The Dow Chemical Company Haze-free cellulose ether capsules and process for making
DE60020716T2 (de) 1999-07-22 2005-12-15 Warner-Lambert Co. Llc Filmbildende zusammensetzungen aus pullulan
KR100379674B1 (ko) 2000-03-06 2003-04-10 주식회사 서흥캅셀 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법
GB2366780A (en) 2000-07-07 2002-03-20 Bioprogress Tech Int Inc Foam capsules
EP1184033A1 (en) 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
JP2002145783A (ja) 2000-11-06 2002-05-22 Kohjin Co Ltd S−アデノシルメチオニンまたはその塩類を含有するカプセル製剤
US20030072731A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
GB0221986D0 (en) 2002-09-21 2002-10-30 Bioprogress Technology Ltd Films with improved barrier properties
JP2006506382A (ja) * 2002-10-22 2006-02-23 イーストゲイト・インベスティメンツ・リミテッド アラビアガム含有カプセルおよびフィルム形成組成物
TW200520790A (en) 2003-12-22 2005-07-01 Dah Feng Capsule Industry Co Ltd The compositions of a vegetarian capsule shell
WO2005113010A1 (ja) 2004-05-24 2005-12-01 Qualicaps Co., Ltd. 表面改質および溶解性が改善された硬カプセル
WO2006043284A1 (en) 2004-10-21 2006-04-27 Sunil Mundra A process for manufacturing neutraceutical, pharmaceutical cellulose derivatives capsule
WO2006070578A1 (ja) 2004-12-28 2006-07-06 Qualicaps Co., Ltd. 硬カプセルのバンドシール
KR100661336B1 (ko) 2005-02-21 2006-12-27 주식회사 서흥캅셀 기계적 피막강도를 향상시킨 셀룰로오스 경질캅셀
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
US20070043284A1 (en) 2005-08-16 2007-02-22 Robert Sanfilippo Medical electrode and method of use
EP1762232A1 (en) 2005-09-09 2007-03-14 Warner-Lambert Company LLC Liquid filled delivery system, preferably an HPMC capsule filled with glycerol
EP1983969A4 (en) 2006-01-24 2012-10-31 Qualicaps Co Ltd HARD CAPSULE WITH LOW MOISTURE CONTENT AND MANUFACTURING METHOD THEREFOR
WO2007098612A1 (en) 2006-03-02 2007-09-07 Laboratoires Mauves Inc. Gastric acid resistant gelatin capsule composition and method for producing same
US20080075767A1 (en) * 2006-06-30 2008-03-27 Jin Xiao P Ibuprofen-containing liquid filled hard capsules
CN101595133B (zh) 2006-10-27 2012-11-14 比利时胶囊公司 羟丙基甲基纤维素硬胶囊及制备方法
GB0706178D0 (en) 2007-03-29 2007-05-09 Univ Aston Enteric pharmaceutical capsules
WO2009021377A1 (en) * 2007-08-10 2009-02-19 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin shell material of hard capsule and process for preparing thereof
WO2009062356A1 (en) 2007-11-13 2009-05-22 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin enteric hard capsule shell and preparation method thereof
JP5178236B2 (ja) * 2008-02-25 2013-04-10 クオリカプス株式会社 腸溶性カプセル
US8825387B2 (en) 2008-07-25 2014-09-02 Navteq B.V. Positioning open area maps
JP5253235B2 (ja) * 2009-03-02 2013-07-31 クオリカプス株式会社 腸溶性カプセル
EP2496219A1 (en) 2009-06-29 2012-09-12 McNeil-PPC, Inc. Pharmaceutical tablet containing a liquid filled capsule
KR20120061955A (ko) 2009-09-04 2012-06-13 캡슈겔 벨지엄 엔브이 방향 캡슐
US8852631B2 (en) 2009-09-24 2014-10-07 Capsugel Belgium Nv Acid resistant capsules
WO2013038271A1 (en) 2011-09-14 2013-03-21 Capsugel Belgium Nv Fill formulations and capsules and method of use to avoid migration of fill into or through the shell
JP2014172850A (ja) 2013-03-07 2014-09-22 Capsugel Belgium Nv ハードカプセル製剤
WO2016017006A1 (ja) 2014-07-31 2016-02-04 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップ カプセル製剤
WO2016099921A1 (en) 2014-12-16 2016-06-23 E. I. Du Pont De Nemours And Company Films, fluoropolymer coated films and highly cleanable articles
TWI587880B (zh) 2015-03-24 2017-06-21 Can be made into the composition of enteric capsule shell, enteric capsule shell and its process
US9452141B1 (en) 2015-05-01 2016-09-27 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process
US20170157058A1 (en) 2015-12-08 2017-06-08 Dah Feng Capsule Industry Co., Ltd. Acid resistant capsule shell composition, acid resistant capsule shell and its preparing process

Also Published As

Publication number Publication date
CA2775227C (en) 2017-12-19
US20170231918A1 (en) 2017-08-17
BR112012006651B1 (pt) 2021-11-03
EP2480218A1 (en) 2012-08-01
KR20120079836A (ko) 2012-07-13
TW201127370A (en) 2011-08-16
JP5777625B2 (ja) 2015-09-09
US10874619B2 (en) 2020-12-29
RU2012116362A (ru) 2013-10-27
US20150050334A1 (en) 2015-02-19
US8852631B2 (en) 2014-10-07
DK2480218T3 (da) 2020-08-24
EP2480218B1 (en) 2020-05-27
BR112012006651A2 (pt) 2020-08-11
CO6531471A2 (es) 2012-09-28
AU2010299527A1 (en) 2012-04-19
CA2775227A1 (en) 2011-03-31
US10231934B2 (en) 2019-03-19
US9700517B2 (en) 2017-07-11
MX2012003540A (es) 2012-09-07
CN102665697A (zh) 2012-09-12
ES2804779T3 (es) 2021-02-09
US20120288562A1 (en) 2012-11-15
WO2011036601A1 (en) 2011-03-31
CN102665697B (zh) 2014-07-09
US20190175514A1 (en) 2019-06-13
JP2013505928A (ja) 2013-02-21
KR101762460B1 (ko) 2017-07-27

Similar Documents

Publication Publication Date Title
PL2480218T3 (pl) Kapsułki odporne na kwas
PT2391559E (pt) Cápsula contendo uma dose
EP2455953A4 (en) REACTOR
GB0916335D0 (en) Medicaments
GB201103481D0 (en) No details
GB201016096D0 (en) No details
GB0902231D0 (en) Catayst
EP2443235A4 (en) ß-glucosidase VARIANTS
EP2315534A4 (en) CHEESE GEL CAPSULES
GB201016097D0 (en) No details
PL2448439T3 (pl) Trykot
GB0909909D0 (en) Microcapsules containing microrgnisms
ZA201109025B (en) Sustained release capsules
IL215962A0 (en) Soilid preparation
GB0914596D0 (en) Improved hatchcover
EP2421005A4 (en) REACTOR
GB0922589D0 (en) Pharmaceutical compounds
GB0914038D0 (en) Connection
IL208602A0 (en) Mezuzah case
GB0916332D0 (en) Medicaments
GB0908905D0 (en) Pharmaceutical compounds
GB2470139B (en) Case design
GB0922537D0 (en) Pharmaceutical preparation
GB0917775D0 (en) Novel pharmaceutical compounds
GB0917774D0 (en) Novel pharmaceutical compounds